| Original language | Undefined/Unknown |
|---|---|
| Pages (from-to) | 6-7 |
| Number of pages | 2 |
| Journal | British Journal of Cancer |
| Volume | 83 |
| Issue number | 1 |
| Publication status | Published - 2000 |
Research programs
- EMC MM-03-47-11
What can we learn from phase II adjuvant trials in melanoma?
U Keilholz, S Suciu, Lex Eggermont
Research output: Contribution to journal › Article › Academic › peer-review
1
Citation
(Scopus)